Cargando…

Find the Flame: Predictive Biomarkers for Immunotherapy in Melanoma

SIMPLE SUMMARY: Immunotherapy has revolutionized the therapeutic landscape of melanoma. However, the absence of clinically validated predictive biomarkers is one of the major causes of unpredictable efficacy of immunotherapy. Indeed, the availability of predictive biomarkers could allow a better str...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garutti, Mattia, Bonin, Serena, Buriolla, Silvia, Bertoli, Elisa, Pizzichetta, Maria Antonietta, Zalaudek, Iris, Puglisi, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070445/ https://www.ncbi.nlm.nih.gov/pubmed/33920288 http://dx.doi.org/10.3390/cancers13081819

Ejemplares similares

“To Anticipate”: Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers
por: Garutti, Mattia, et al.
Publicado: (2020)

CDK4/6 Inhibitors in Melanoma: A Comprehensive Review
por: Garutti, Mattia, et al.
Publicado: (2021)

A group of three miRNAs can act as candidate circulating biomarkers in liquid biopsies from melanoma patients
por: De Martino, Eleonora, et al.
Publicado: (2023)

BRAF and MEK Inhibitors and Their Toxicities: A Meta-Analysis
por: Garutti, Mattia, et al.
Publicado: (2022)

Is There More Than One Road to Nevus-Associated Melanoma?
por: Vezzoni, Roberta, et al.
Publicado: (2020)

Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma
por: Puglisi, Rossella, et al.
Publicado: (2021)

Over-diagnosis, Overtreatment or Oversurveillance of Melanoma: Is There a Way Out?
por: Zalaudek, Iris
Publicado: (2023)

Epidemiology and Risk Factors of Melanoma: A Review
por: Conforti, Claudio, et al.
Publicado: (2021)

Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response
por: Zelin, Enrico, et al.
Publicado: (2022)

Amelanotic/hypomelanotic lentigo maligna: Dermoscopic and confocal features predicting diagnosis
por: Pizzichetta, Maria A., et al.
Publicado: (2022)

Management of patients with melanoma and non-melanoma skin cancers in the coronavirus disease 2019 era
por: Conforti, Claudio, et al.
Publicado: (2020)

Seven Shades of Black Thoughts: COVID-19 and Its Psychological Consequences on Cancer Patients
por: Garutti, Mattia, et al.
Publicado: (2020)

Immunotherapy in NSCLC Patients with Brain Metastases
por: Buriolla, Silvia, et al.
Publicado: (2022)

Melanoma Immunotherapy: Next-Generation Biomarkers
por: Hogan, Sabrina A., et al.
Publicado: (2018)

Yellow color upon dermatoscopy does not exclude melanoma!
por: Longo, Caterina, et al.
Publicado: (2014)

Actinic Keratoses: A Prospective Pilot Study on a Novel Formulation of 4% 5-Fluorouracil Cream and a Review of Other Current Topical Treatment Options
por: Toffoli, Ludovica, et al.
Publicado: (2023)

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2020)

Melanoma in pregnancy: certainties unborn
por: Zelin, Enrico, et al.
Publicado: (2020)

The value of pre-surgical photography in the management of melanoma
por: Zalaudek, Iris, et al.
Publicado: (2017)

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
por: Nyakas, M., et al.
Publicado: (2019)

Melanoma and satellite blue papule
por: Oliveira, André, et al.
Publicado: (2014)

An unusual case of compound naevus of the scalp with hair greying, suggesting melanoma in dermoscopy
por: Kaminska-Winciorek, Grazyna, et al.
Publicado: (2020)

The Association of Residential Altitude on the Molecular Profile and Survival of Melanoma: Results of an Interreg Study
por: De Martino, Eleonora, et al.
Publicado: (2020)

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study
por: Basile, Debora, et al.
Publicado: (2021)

Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review
por: Tagliaferri, Luca, et al.
Publicado: (2021)

Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers
por: Spiliopoulou, Pavlina, et al.
Publicado: (2023)

Unusual dermoscopic patterns of basal cell carcinoma mimicking melanoma
por: Di Matteo, Eleonora, et al.
Publicado: (2022)

NOTCH4 mutation as predictive biomarker for immunotherapy benefits in NRAS wildtype melanoma
por: Li, Hongxia, et al.
Publicado: (2022)

Dermoscopic characteristics of melanoma according to the criteria „ulceration“ and „mitotic rate“ of the AJCC 2009 staging system for melanoma
por: Deinlein, Teresa, et al.
Publicado: (2017)

Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors
por: Garutti, Mattia, et al.
Publicado: (2019)

Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma Immunotherapy
por: Olekhnovich, Evgenii I., et al.
Publicado: (2023)

The Multiple Potential Biomarkers for Predicting Immunotherapy Response—Finding the Needle in the Haystack
por: Adam, Tamiem, et al.
Publicado: (2021)

Immunotherapy of melanoma
por: Haanen, John B.A.G.
Publicado: (2013)

Melanoma immunotherapy
por: Garg, Abhishek D., et al.
Publicado: (2015)

Immunotherapy of melanoma
por: Lugowska, Iwona, et al.
Publicado: (2018)

Hypomelanotic melanoma detected by the “little red riding hood sign” in a patient with neurofibromatosis type 1
por: Giuffrida, Roberta, et al.
Publicado: (2017)

Clinical, dermoscopic and histopathologic findings of retiform hemangioendothelioma
por: Mota, Amanda, et al.
Publicado: (2013)

Sex and Gender Disparities in Melanoma
por: Bellenghi, Maria, et al.
Publicado: (2020)

FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma
por: Wu, Shaobo, et al.
Publicado: (2022)

Immune Cell Networks Uncover Candidate Biomarkers of Melanoma Immunotherapy Response
por: Vo, Duong H. T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l8o6psp4pr8fbbois87gj5kmkl